Nation
World
Politics
Sports
Business
Entertainment
Life
Tech
Science
Opinion
Crime
Health
Oddities

Moderna-Merck vaccine cuts odds of skin cancer recurrence in half, study finds

Por: CBS News Health December 15, 2023

thumbnail

A vaccine shows promising results in treating the most deadly form of skin cancer, Moderna and Merck announced on Thursday.Those with severe melanomas who received the vaccine and Merck's cancer drug Keytruda were 49% less likely to die or have their cancer come back after three years than those who were given only Keytruda, the biotech companies said in a news . The findings are based on an ongoing randomized trial involving 157 patients... + full article



Similar News

Merck, Moderna detail potential skin cancer vaccine progress

ABC News USA Business December 14, 2022

thumbnailModerna’s stock soared Tuesday after the COVID-19 vaccine maker detailed progress in developing a preventive shot for a deadly form of skin cancer.The company said a possible melanoma vaccine it is studying with pharmaceutical giant Merck fared well in a small study of... + más

Merck, Moderna detail potential skin cancer vaccine progress | WPLG Local 10

Merck, Moderna detail potential skin cancer vaccine progress | Associated Press


Merck, Moderna detail potential skin cancer vaccine progress

ABC News USA Health December 14, 2022

thumbnailModerna’s stock soared Tuesday after the COVID-19 vaccine maker detailed progress in developing a preventive shot for a deadly form of skin cancer.The company said a possible melanoma vaccine it is studying with pharmaceutical giant Merck fared well in a small study of... + más

Merck, Moderna detail potential skin cancer vaccine progress | WPLG Local 10

Merck, Moderna detail potential skin cancer vaccine progress | Associated Press


Moderna, Merck announce progress in vaccine against skin cancer to significantly boost survival rate

ABC7 USA Health December 14, 2022

thumbnail.The company said a possible melanoma vaccine it is studying with pharmaceutical giant Merck fared well in a small study of patients who had the cancer surgically removed.The drugmakers said a combination of the vaccine and Merck's immunotherapy Keytruda led to a... + más

Merck, Moderna detail potential skin cancer vaccine progress | WPLG Local 10

Merck, Moderna detail potential skin cancer vaccine progress | Associated Press


Moderna and Merck team-up to fight melanoma

Fox Business USA Business December 13, 2022

thumbnailRodney Smith Jr. and Yuri Williams discuss their mission to help children in need on 'Making Money with Charles Payne.' A Tuesday shows the vaccine-maker’s collaboration with biopharma Merck will help patients fight an aggressive form of skin cancer.  In a joint... + más

Merck, Moderna detail potential skin cancer vaccine progress | WPLG Local 10

Merck, Moderna detail potential skin cancer vaccine progress | Associated Press


Merck, Moderna detail potential skin cancer vaccine progress

WPLG Local 10 USA Health December 13, 2022

thumbnailModerna’s stock soared Tuesday after the COVID-19 vaccine maker detailed progress in developing a preventive shot for a deadly form of skin cancer.The company said a possible melanoma vaccine it is studying with pharmaceutical giant Merck fared well in a small study of... + más

Merck, Moderna detail potential skin cancer vaccine progress | Associated Press

Merck, Moderna detail potential skin cancer vaccine progress | ABC News


Merck, Moderna detail potential skin cancer vaccine progress

Associated Press USA Health December 13, 2022

Moderna’s stock soared Tuesday after the COVID-19 vaccine maker detailed progress in developing a preventive shot for a deadly form of skin cancer.The company said a possible melanoma vaccine it is studying with pharmaceutical giant Merck fared well in a small study of... + más

Merck, Moderna detail potential skin cancer vaccine progress | WPLG Local 10

Merck, Moderna detail potential skin cancer vaccine progress | ABC News


Merck, Moderna detail potential skin cancer vaccine progress

10 WBNS USA Nation December 13, 2022

thumbnailCAMBRIDGE, Mass. — Shares of Merck and Moderna jumped Tuesday after the drugmakers said a potential skin cancer vaccine they are developing using the same technology behind COVID-19 preventive shots fared well in a small study. The drugmakers said a combination of the vaccine... + más

Merck, Moderna detail potential skin cancer vaccine progress | WPLG Local 10

Merck, Moderna detail potential skin cancer vaccine progress | Associated Press



About iurex | Privacy Policy | Disclaimer |